Insulin Delivery Devices Market Research Report: By Type (Insulin Pen, Insulin Pump, Insulin Syringe), Distribution Channel (Pharmacies, Diabetes Clinics/Centers, E-Commerce), End Use (Home-Use, Hospitals)

Description

List of Tables

The insulin delivery devices market 2030 revenue will likely be $39,371.8 million, compared to an estimated $16,008.0 million in 2021. According to the market report published by P&S Intelligence. Among all the devices used for administering this peptide hormone into the body, insulin pens are used the most. Pens are easier to use by individuals on themselves compared to syringes and cheaper compared to insulin pumps and other devices.

Moreover, reusable pens are cost-effective in the long run, as a single pen can be used for a long time just by simply changing the vial/refill. Therefore, seeing the growing popularity of these devices, companies that produce them are enhancing their sales and distribution network in countries with a large diabetic population, such as China and India. Similarly, in developed countries, technologically advanced pens and ample medical reimbursements on their purchase are available.

Key Findings of Insulin Delivery Devices Market Report

The biggest reason behind the rising demand for insulin delivery devices is diabetes, which either results in insulin resistance or the stoppage in the production of this hormone.

The IDF recorded the global prevalence of this endocrine disorder at 463 million in 2019, forecasting it to reach 578 million and 700.2 million by 2030 and 2045, respectively.

Along with this, another key driver for the insulin delivery devices market is the growing number of obese people. Obesity, which is now considered an independent risk factor for diabetes, is a result of genetics or poor lifestyle choices.

Another factor that ups the risk of this disease is aging, with a larger number of people aged above 45 years suffering from this disorder compared to younger people.

Since many of the older people are not yet as comfortable with digital technologies, pharmacies continue to be the preferred place for them to buy insulin delivery devices.

Currently, North America is the largest insulin delivery devices market because of the highly fatty diet of a large number of people, which leads to obesity and, often, diabetes. Moreover, the region has been among the first to accept technologically advanced methods of administering this hormone into the body.

In the years to come, market players will find numerous growth opportunities in the APAC region, which is home to the largest diabetic population in the world. This, combined with the increasing awareness on a strict care regimen, is propelling the sale of insulin delivery devices. Among the various kinds of insulin pens, pumps, and other devices, those meant for home use continue to be the most popular.

Thus, key insulin delivery devices market players, such as Becton, Dickinson and Company, Tandem Diabetes Care Inc., Medtronic plc, Biocon Ltd., Insulet Corporation, Eli Lilly and Company, Novo Nordisk A/S, Ypsomed Holding AG, Sanofi, F. Hoffmann-La Roche Ltd., Braun Melsungen AG, Wockhardt Ltd., and Gulf Pharmaceutical Industries, are doing more to target the at-home consumer base. A key move in this regard is the introduction of insulin delivery devices that do not require fingersticks for calibration.

Product Code: 10326

Chapter 1. Research Background

1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.5 Market Size Breakdown by Segment
- 1.5.1 Market Segmentation by Type
- 1.5.2 Market Segmentation by Distribution Channel
- 1.5.3 Market Segmentation by End Use
- 1.5.4 Market Segmentation by Region
- 1.5.5 Market Segment Analysis of Countries
1.6 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Region
- 2.2.2 Breakdown of Primary Research, by Industry Participant
- 2.2.3 Breakdown of Primary Research, by Designation
- 2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Definition of Market Segments

4.1 By Product
- 4.1.1 Insulin Pen
  - 4.1.1.1 Reusable pens
  - 4.1.1.2 Disposable pens
- 4.1.2 Insulin Pump
  - 4.1.2.1 External/Tethered pumps
  - 4.1.2.2 Patch pumps
- 4.1.3 Insulin Syringe
- 4.1.4 Others
4.2 By Distribution Channel
- 4.2.1 Pharmacies
- 4.2.2 E-Commerce
- 4.2.3 Diabetes Clinics/Centers

Chapter 5. Industry Outlook

5.1 Market Dynamics
- 5.1.1 Trends
  - 5.1.1.1 Surge in the launch of insulin delivery devices
  - 5.1.1.2 Growing significance of home infusion therapy for diabetes treatment
- 5.1.2 Drivers
  - 5.1.2.1 Growing diabetic population
  - 5.1.2.2 Technological advancements in insulin delivery devices
  - 5.1.2.3 Surging aging population
- 5.1.3 Impact Analysis of Drivers on Market Forecast
- 5.1.4 Restraints
  - 5.1.4.1 Stringent regulatory requirements
  - 5.1.4.2 Complex manufacturing of syringes
- 5.1.5 Impact Analysis of Restraints on Market Forecast
5.2 Impact of COVID-19
5.3 Porter's Five Forces Analysis
- 5.3.1 Bargaining Power of Buyers
- 5.3.2 Bargaining Power of Suppliers
- 5.3.3 Intensity of Rivalry
- 5.3.4 Threat of New Entrants
- 5.3.5 Threat of Substitutes

Chapter 6. Global Market Size and Forecast

6.1 Overview
6.2 Market Revenue, by Type (2015-2030)
- 6.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 6.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
6.3 Market Revenue, by Distribution Channel (2015-2030)
6.4 Market Revenue, by End Use (2015-2030)
6.5 Market Revenue, by Region (2015-2030)

Chapter 7. North America Market Size and Forecast

7.1 Overview
7.2 Market Revenue, by Type (2015-2030)
- 7.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 7.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
7.3 Market Revenue, by Distribution Channel (2015-2030)
7.4 Market Revenue, by End Use (2015-2030)
7.5 Market Revenue, by Country (2015-2030)

Chapter 8. Europe Market Size and Forecast

8.1 Overview
8.2 Market Revenue, by Type (2015-2030)
- 8.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 8.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
8.3 Market Revenue, by Distribution Channel (2015-2030)
8.4 Market Revenue, by End Use (2015-2030)
8.5 Market Revenue, by Country (2015-2030)

Chapter 9. APAC Market Size and Forecast

9.1 Overview
9.2 Market Revenue, by Type (2015-2030)
- 9.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 9.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
9.3 Market Revenue, by Distribution Channel (2015-2030)
9.4 Market Revenue, by End Use (2015-2030)
9.5 Market Revenue, by Country (2015-2030)

Chapter 10. LATAM Market Size and Forecast

10.1 Overview
10.2 Market Revenue, by Type (2015-2030)
- 10.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 10.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
10.3 Market Revenue, by Distribution Channel (2015-2030)
10.4 Market Revenue, by End Use (2015-2030)
10.5 Market Revenue, by Country (2015-2030)

Chapter 11. MEA Market Size and Forecast

11.1 Overview
11.2 Market Revenue, by Type (2015-2030)
- 11.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 11.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
11.3 Market Revenue, by Distribution Channel (2015-2030)
11.4 Market Revenue, by End Use (2015-2030)
11.5 Market Revenue, by Country (2015-2030)

Chapter 12. U.S. Market Size and Forecast

12.1 Market Revenue, by Type (2015-2030)
- 12.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 12.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
12.2 Market Revenue, by Distribution Channel (2015-2030)
12.3 Market Revenue, by End Use (2015-2030)

Chapter 13. Canada Market Size and Forecast

13.1 Market Revenue, by Type (2015-2030)
- 13.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 13.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
13.2 Market Revenue, by Distribution Channel (2015-2030)
13.3 Market Revenue, by End Use (2015-2030)

Chapter 14. Germany Market Size and Forecast

14.1 Market Revenue, by Type (2015-2030)
- 14.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 14.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
14.2 Market Revenue, by Distribution Channel (2015-2030)
14.3 Market Revenue, by End Use (2015-2030)

Chapter 15. France Market Size and Forecast

15.1 Market Revenue, by Type (2015-2030)
- 15.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 15.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
15.2 Market Revenue, by Distribution Channel (2015-2030)
15.3 Market Revenue, by End Use (2015-2030)

Chapter 16. U.K. Market Size and Forecast

16.1 Market Revenue, by Type (2015-2030)
- 16.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 16.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
16.2 Market Revenue, by Distribution Channel (2015-2030)
16.3 Market Revenue, by End Use (2015-2030)

Chapter 17. Italy Market Size and Forecast

17.1 Market Revenue, by Type (2015-2030)
- 17.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 17.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
17.2 Market Revenue, by Distribution Channel (2015-2030)
17.3 Market Revenue, by End Use (2015-2030)

Chapter 18. Spain Market Size and Forecast

18.1 Market Revenue, by Type (2015-2030)
- 18.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 18.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
18.2 Market Revenue, by Distribution Channel (2015-2030)
18.3 Market Revenue, by End Use (2015-2030)

Chapter 19. China Market Size and Forecast

19.1 Market Revenue, by Type (2015-2030)
- 19.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 19.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
19.2 Market Revenue, by Distribution Channel (2015-2030)
19.3 Market Revenue, by End Use (2015-2030)

Chapter 20. Japan Market Size and Forecast

20.1 Market Revenue, by Type (2015-2030)
- 20.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 20.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
20.2 Market Revenue, by Distribution Channel (2015-2030)
20.3 Market Revenue, by End Use (2015-2030)

Chapter 21. India Market Size and Forecast

21.1 Market Revenue, by Type (2015-2030)
- 21.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 21.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
21.2 Market Revenue, by Distribution Channel (2015-2030)
21.3 Market Revenue, by End Use (2015-2030)

Chapter 22. Brazil Market Size and Forecast

22.1 Market Revenue, by Type (2015-2030)
- 22.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 22.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
22.2 Market Revenue, by Distribution Channel (2015-2030)
22.3 Market Revenue, by End Use (2015-2030)

Chapter 23. Mexico Market Size and Forecast

23.1 Market Revenue, by Type (2015-2030)
- 23.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 23.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
23.2 Market Revenue, by Distribution Channel (2015-2030)
23.3 Market Revenue, by End Use (2015-2030)

Chapter 24. Saudi Arabia Market Size and Forecast

24.1 Market Revenue, by Type (2015-2030)
- 24.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 24.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
24.2 Market Revenue, by Distribution Channel (2015-2030)
24.3 Market Revenue, by End Use (2015-2030)

Chapter 25. South Africa Market Size and Forecast

25.1 Market Revenue, by Type (2015-2030)
- 25.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 25.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
25.2 Market Revenue, by Distribution Channel (2015-2030)
25.3 Market Revenue, by End Use (2015-2030)

Chapter 26. U.A.E. Market Size and Forecast

26.1 Market Revenue, by Type (2015-2030)
- 26.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
- 26.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
26.2 Market Revenue, by Distribution Channel (2015-2030)
26.3 Market Revenue, by End Use (2015-2030)

Chapter 27. Competitive Landscape

27.1 Market Share of Key Players (2021)
27.1 List of Market Players and Their Offerings
27.2 Strategic Developments Key Players
- 27.2.1 Product Launches and Approvals
- 27.2.2 Partnerships
- 27.2.3 Mergers and Acquisitions
- 27.2.4 Other Developments

Chapter 28. Company Profile

28.1 Becton, Dickinson and Company
- 28.1.1 Business Overview
- 28.1.2 Product and Service Offerings
- 28.1.3 Key Financial Summary
28.2 Medtronic plc
- 28.2.1 Business Overview
- 28.2.2 Product and Service Offerings
- 28.2.3 Key Financial Summary
28.3 Tandem Diabetes Care Inc.
- 28.3.1 Business Overview
- 28.3.2 Product and Service Offerings
- 28.3.3 Key Financial Summary
28.4 Biocon Limited
- 28.4.1 Business Overview
- 28.4.2 Product and Service Offerings
- 28.4.3 Key Financial Summary
28.5 Eli Lilly and Company
- 28.5.1 Business Overview
- 28.5.2 Product and Service Offerings
- 28.5.3 Key Financial Summary
28.6 Novo Nordisk A/S
- 28.6.1 Business Overview
- 28.6.2 Product and Service Offerings
- 28.6.3 Key Financial Summary
28.7 Sanofi
- 28.7.1 Business Overview
- 28.7.2 Product and Service Offerings
- 28.7.3 Key Financial Summary
28.8 Ypsomed AG
- 28.8.1 Business Overview
- 28.8.2 Product and Service Offerings
- 28.8.3 Key Financial Summary
28.9 F. Hoffmann-La Roche Ltd.
- 28.9.1 Business Overview
- 28.9.2 Product and Service Offerings
- 28.9.3 Key Financial Summary
28.10 Insulet Corporation
- 28.10.1 Business Overview
- 28.10.2 Product and Service Offerings
- 28.10.3 Key Financial Summary
28.11 B. Braun Melsungen AG
- 28.11.1 Business Overview
- 28.11.2 Product and Service Offerings
- 28.11.3 Key Financial Summary
28.12 Wockhardt Limited
- 28.12.1 Business Overview
- 28.12.2 Product and Service Offerings
- 28.12.3 Key Financial Summary

Chapter 29. Appendix

29.1 Abbreviations
29.2 Sources and References
29.3 Related Reports